GPR120
内分泌学
内科学
受体
游离脂肪酸受体1
糖尿病
胰岛素抵抗
2型糖尿病
肥胖
生物
G蛋白偶联受体
医学
兴奋剂
作者
Xiulei Mo,Hong Wei,Jian Peng,Ya-Xiong Tao
出处
期刊:Progress in Molecular Biology and Translational Science
日期:2013-01-01
卷期号:: 251-276
被引量:26
标识
DOI:10.1016/b978-0-12-386933-3.00007-8
摘要
G protein-coupled receptor 120 (GPR120) was initially identified as an orphan receptor through mining the human genome databases. In 2005, GPR120 was deorphanized and shown to be a receptor for long-chain free fatty acids. GPR120 regulates various physiological processes, including gut hormone secretion, islet function, food preference, osteoclastogenesis, anti-inflammation, adipogenesis, and appetite control. Recently, a human genetic study conducted in European populations identified a loss-of-function GPR120 mutation associated with obesity and insulin resistance. Therefore, GPR120, the sensing receptor for long-chain free fatty acids, represents a novel drug target for the treatment of obesity and diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI